The Manufacturers Life Insurance Company lessened its holdings in shares of Zoetis Inc (NYSE:ZTS) by 11.7% in the 4th quarter, Holdings Channel reports. The firm owned 488,446 shares of the company’s stock after selling 64,976 shares during the quarter. The Manufacturers Life Insurance Company ‘s holdings in Zoetis were worth $35,188,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of ZTS. Janus Henderson Group PLC raised its stake in Zoetis by 1.5% in the 3rd quarter. Janus Henderson Group PLC now owns 5,893,853 shares of the company’s stock worth $375,792,000 after acquiring an additional 84,767 shares during the last quarter. Wells Fargo & Company MN raised its stake in Zoetis by 4.7% in the 4th quarter. Wells Fargo & Company MN now owns 5,313,643 shares of the company’s stock worth $382,795,000 after acquiring an additional 238,061 shares during the last quarter. Legal & General Group Plc raised its stake in Zoetis by 1.5% in the 3rd quarter. Legal & General Group Plc now owns 2,400,106 shares of the company’s stock worth $153,025,000 after acquiring an additional 34,747 shares during the last quarter. Frontier Capital Management Co. LLC raised its stake in Zoetis by 1.3% in the 3rd quarter. Frontier Capital Management Co. LLC now owns 2,140,589 shares of the company’s stock worth $136,484,000 after acquiring an additional 26,902 shares during the last quarter. Finally, Bessemer Group Inc. raised its stake in Zoetis by 231,590.8% in the 4th quarter. Bessemer Group Inc. now owns 2,117,654 shares of the company’s stock worth $152,557,000 after acquiring an additional 2,116,740 shares during the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.
A number of brokerages recently issued reports on ZTS. Deutsche Bank raised their target price on Zoetis from $76.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, February 16th. Stifel Nicolaus restated a “buy” rating and issued a $86.00 target price (up previously from $84.00) on shares of Zoetis in a research note on Friday, February 16th. Bank of America raised their target price on Zoetis from $80.00 to $87.00 and gave the stock a “buy” rating in a research note on Friday, February 16th. Piper Jaffray Companies set a $88.00 target price on Zoetis and gave the stock a “buy” rating in a research note on Friday, February 16th. Finally, BMO Capital Markets set a $78.00 target price on Zoetis and gave the stock a “hold” rating in a research note on Thursday, February 15th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $79.83.
Zoetis Inc (ZTS) opened at $80.35 on Wednesday. The firm has a market capitalization of $38,689.28, a PE ratio of 33.22, a price-to-earnings-growth ratio of 1.80 and a beta of 1.07. Zoetis Inc has a 52 week low of $52.25 and a 52 week high of $81.47. The company has a debt-to-equity ratio of 2.77, a quick ratio of 2.55 and a current ratio of 3.85.
Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, February 15th. The company reported $0.69 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.03. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.40 billion. Zoetis had a return on equity of 65.96% and a net margin of 16.28%. The company’s revenue was up 14.3% on a year-over-year basis. During the same quarter last year, the business posted $0.47 EPS. equities research analysts expect that Zoetis Inc will post 3.02 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 1st. Shareholders of record on Friday, April 20th will be paid a dividend of $0.126 per share. The ex-dividend date is Thursday, April 19th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.63%. Zoetis’s payout ratio is currently 28.57%.
TRADEMARK VIOLATION WARNING: This news story was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/21/the-manufacturers-life-insurance-company-has-35-19-million-stake-in-zoetis-inc-zts.html.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.